LY-33169
LY-33169 is an antitumor agent. LY-33169 had selective cytotoxicity against Colon Adenocarcinoma-38, Human Colon-116, Human Prostate LNCaP, and Human Breast WSU-Br-1 cells[1].
Product Specifications
CAS Number
[477844-47-6]
UNSPSC
12352005
Target
Others
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
99.56
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=C(C=C1Cl)Cl)NS(=O)(C2=CC=C(C=C2)Cl)=O
Molecular Formula
C13H8Cl3NO3S
Molecular Weight
364.63
References & Citations
[1]Corbett TH, et al. Discovery and preclinical antitumor efficacy evaluations of LY32262 and LY33169. Invest New Drugs. 2003 Feb;21 (1) :33-45.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6011833-01 0.1 mL
EIF4G3 (Eukaryotic Translation Initiation Factor 4 gamma 3, eIF-4-gamma 3, eIF-4G 3, eIF4G 3, eIF-4-gamma II, eIF4GII)
Ask
View Details 
MBS6011833-02 5x 0.1 mL
EIF4G3 (Eukaryotic Translation Initiation Factor 4 gamma 3, eIF-4-gamma 3, eIF-4G 3, eIF4G 3, eIF-4-gamma II, eIF4GII)
Ask
View Details RC231278L3 10 µg
Sohlh2 (CCDC169-SOHLH2) (NM_001198910) Human Tagged Lenti ORF Clone
Ask
View Details 